i-SENS, Inc. engages in the development, manufacture and sales of medical sensors and measuring instruments based on electrochemical and biosensor technologies. It operates through the Blood Glucose Meter and Point-of-Care business divisions. The Blood Glucose Meter business division is composed of a diagnostic device that allows to measure the amount of glucose in the blood and consists of a blood glucose meter, blood glucose strip, and lancet. The Point-of-Care business division consists of diagnostic testing conducted at the patient’s site, rather than in a central laboratory. The company was founded by Geun-Sig Cha and Hak-Hyun Nam on May 4, 2000 and is headquartered in Seoul, South Korea.